GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Total Debt per Share

Kineta (STU:J75) Total Debt per Share : €0.09 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Total Debt per Share?

€0.09 (As of Mar. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Kineta's Total Debt Per Share for the quarter that ended in Mar. 2024 was €0.09.


Kineta Total Debt per Share Historical Data

The historical data trend for Kineta's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Total Debt per Share Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Debt per Share
4.21 4.40 0.26 0.12

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.18 0.15 0.12 0.09

Kineta Total Debt per Share Calculation

Kineta's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Kineta's Total Debt Per Share for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Kineta's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines